Nothing Special   »   [go: up one dir, main page]

Isganaitis et al., 2015 - Google Patents

Associations of cord blood metabolites with early childhood obesity risk

Isganaitis et al., 2015

View HTML
Document ID
16368555372054751366
Author
Isganaitis E
Rifas-Shiman S
Oken E
Dreyfuss J
Gall W
Gillman M
Patti M
Publication year
Publication venue
International journal of obesity

External Links

Snippet

Methods: We performed a nested case–control study within Project Viva, a longitudinal cohort of mothers and children. We selected cases (n= 26) based on top quartile of change in weight-for-age 0–6 months and body mass index (BMI)> 85th percentile in mid-childhood …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/02—Investigating or analysing materials by specific methods not covered by the preceding groups food
    • G01N33/04—Investigating or analysing materials by specific methods not covered by the preceding groups food dairy products
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment; Prognosis

Similar Documents

Publication Publication Date Title
Isganaitis et al. Associations of cord blood metabolites with early childhood obesity risk
Christ et al. The Western lifestyle has lasting effects on metaflammation
Perng et al. Metabolomic profiles and childhood obesity
Gadgil et al. Imbalance of folic acid and vitamin B12 is associated with birth outcome: an Indian pregnant women study
Moco et al. Metabolomics perspectives in pediatric research
Gilsing et al. Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study
Hughes et al. Vitamin B12 and ageing: current issues and interaction with folate
Reyman et al. Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity
Karvonen et al. Gut microbiota and overweight in 3-year old children
Assis et al. Childhood stunting in Northeast Brazil: the role of Schistosoma mansoni infection and inadequate dietary intake
Mussap et al. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites
Størdal et al. Prenatal iron exposure and childhood type 1 diabetes
Rangel-Huerta et al. Metabolic profiling in children with autism spectrum disorder with and without mental regression: Preliminary results from a cross-sectional case–control study
Panjwani et al. Maternal obesity/diabetes, plasma branched‐chain amino acids, and autism spectrum disorder risk in urban low‐income children: Evidence of sex difference
Park et al. Association between the markers of metabolic acid load and higher all-cause and cardiovascular mortality in a general population with preserved renal function
Chen et al. Association between vitamin D status and cognitive impairment in acute ischemic stroke patients: a prospective cohort study
Hu et al. Gut microbiota signature of obese adults across different classifications
Obermajer et al. Microbes in infant gut development: placing abundance within environmental, clinical and growth parameters
Walser et al. Intention retrieval and deactivation following an acute psychosocial stressor
Paxman et al. Prenatal maternal stress from a natural disaster alters urinary metabolomic profiles in project ice storm participants
Meng et al. The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China: a cross-sectional study
Knight et al. Association between one-carbon metabolism indices and DNA methylation status in maternal and cord blood
Morris et al. Reduction in newborn screening metabolic false-positive results following a new collection protocol
Holzhausen et al. Longitudinal profiles of the fecal metabolome during the first 2 years of life
Vahid et al. The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case–control study